"RNA, Antisense" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
RNA molecules which hybridize to complementary sequences in either RNA or DNA altering the function of the latter. Endogenous antisense RNAs function as regulators of gene expression by a variety of mechanisms. Synthetic antisense RNAs are used to effect the functioning of specific genes for investigative or therapeutic purposes.
| Descriptor ID |
D016372
|
| MeSH Number(s) |
D13.150.650 D13.444.600.150.760 D13.444.735.150 D27.720.470.530.600.150.760
|
| Concept/Terms |
RNA, Antisense- RNA, Antisense
- Antisense RNA
- Anti-Sense RNA
- Anti Sense RNA
- RNA, Anti-Sense
|
Below are MeSH descriptors whose meaning is more general than "RNA, Antisense".
Below are MeSH descriptors whose meaning is more specific than "RNA, Antisense".
This graph shows the total number of publications written about "RNA, Antisense" by people in this website by year, and whether "RNA, Antisense" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 3 | 4 |
| 1995 | 3 | 1 | 4 |
| 1996 | 1 | 3 | 4 |
| 1997 | 1 | 3 | 4 |
| 1998 | 1 | 3 | 4 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 2 | 3 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 1 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 1 | 3 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "RNA, Antisense" by people in Profiles.
-
Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity. Oncogene. 2023 09; 42(36):2673-2687.
-
AFAP1-AS1: a rising star among oncogenic long non-coding RNAs. Sci China Life Sci. 2021 Oct; 64(10):1602-1611.
-
Long noncoding RNA BHLHE40-AS1 promotes early breast cancer progression through modulating IL-6/STAT3 signaling. J Cell Biochem. 2020 07; 121(7):3465-3478.
-
A bipartite boundary element restricts UBE3A imprinting to mature neurons. Proc Natl Acad Sci U S A. 2019 02 05; 116(6):2181-2186.
-
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. Int J Mol Sci. 2018 08 21; 19(9).
-
RNA toxicity and foci formation in microsatellite expansion diseases. Curr Opin Genet Dev. 2017 Jun; 44:17-29.
-
VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells. Mol Cancer Res. 2015 Sep; 13(9):1274-82.
-
Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Nature. 2015 Feb 19; 518(7539):409-12.
-
Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model. PLoS Genet. 2013; 9(12):e1004039.
-
Profiling of T helper cell-derived small RNAs reveals unique antisense transcripts and differential association of miRNAs with argonaute proteins 1 and 2. Nucleic Acids Res. 2013 Jan; 41(2):1164-77.